Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
AHMED NADIM
President and CEO at Cullinan Therapeutics. Filing since 6 Jun 2022.
CIK 0001731193
Company
Date
Role
Action
Shares
Amount
Of holding
CGEM
Cullinan Therapeutics, Inc.
24 Feb 2026
President and CEO
Sold at will
13,515
$195.56K
3.3%
CGEM
Cullinan Therapeutics, Inc.
20 Feb 2026
President and CEO
Sold at will
16,381
$223.11K
3.9%
CGEM
Cullinan Therapeutics, Inc.
23 Dec 2025
President and CEO
Sold at will
9,922
$99.32K
2.3%
CGEM
Cullinan Therapeutics, Inc.
25 Feb 2025
President and CEO
Sold at will
12,529
$106.87K
2.8%
CGEM
Cullinan Therapeutics, Inc.
24 Dec 2024
President and CEO
Sold at will
8,400
$99.71K
3.1%
CGEM
Cullinan Therapeutics, Inc.
26 Dec 2023
President and CEO
Sold at will
4,272
$39.47K
3.7%
CGEM
Cullinan Therapeutics, Inc.
28 Jun 2023
President and CEO
Sold at will
759
$8.65K
0.7%
CGEM
Cullinan Therapeutics, Inc.
23 May 2023
President and CEO
Sold at will
707
$6.47K
0.6%
CGEM
Cullinan Therapeutics, Inc.
25 Apr 2023
President and CEO
Sold at will
716
$7.58K
0.6%
CGEM
Cullinan Therapeutics, Inc.
23 Mar 2023
President and CEO
Sold at will
706
$7.42K
0.6%
CGEM
Cullinan Therapeutics, Inc.
6 Jun 2022
President and CEO
Bought
8,090
$100.32K
opened
11 decisions on file.
